WCN24-828 PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION

Saved in:
Bibliographic Details
Main Authors: Rocio Soldati, Sasha Sreckovic, Cristian Brocchieri, Patty Leon, Nadiesh Balachandran, Marianne Uguen, Simon Buatois
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924011926
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849690728617213952
author Rocio Soldati
Sasha Sreckovic
Cristian Brocchieri
Patty Leon
Nadiesh Balachandran
Marianne Uguen
Simon Buatois
author_facet Rocio Soldati
Sasha Sreckovic
Cristian Brocchieri
Patty Leon
Nadiesh Balachandran
Marianne Uguen
Simon Buatois
author_sort Rocio Soldati
collection DOAJ
format Article
id doaj-art-bc29c5a944434ce48870d78dbff7f8f8
institution DOAJ
issn 2468-0249
language English
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-bc29c5a944434ce48870d78dbff7f8f82025-08-20T03:21:14ZengElsevierKidney International Reports2468-02492024-04-0194S52710.1016/j.ekir.2024.02.1103WCN24-828 PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTIONRocio Soldati0Sasha Sreckovic1Cristian Brocchieri2Patty Leon3Nadiesh Balachandran4Marianne Uguen5Simon Buatois6Buenos Aires, PDH, Rare Blood Disorders, ArgentinaPD Safety Risk Management, Genentech, Ltd, San FransiscoHematology and Nephrology Rare Diseases, F. Hoffmann-La Roche Ltd., BaselPDH Rare Blood Disorders, Genentech, Ltd, San Francisco, CASignal Detection, BPO, F. Hoffmann-La Roche Ltd., BaselSignal Detection, BPO, F. Hoffmann-La Roche Ltd., BaselPharmaceutical Sciences, F. Hoffmann-La Roche Ltd., Baselhttp://www.sciencedirect.com/science/article/pii/S2468024924011926
spellingShingle Rocio Soldati
Sasha Sreckovic
Cristian Brocchieri
Patty Leon
Nadiesh Balachandran
Marianne Uguen
Simon Buatois
WCN24-828 PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION
Kidney International Reports
title WCN24-828 PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION
title_full WCN24-828 PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION
title_fullStr WCN24-828 PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION
title_full_unstemmed WCN24-828 PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION
title_short WCN24-828 PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION
title_sort wcn24 828 phase 3 commodore trials of crovalimab in paroxysmal nocturnal hemoglobinuria pnh impact on kidney function
url http://www.sciencedirect.com/science/article/pii/S2468024924011926
work_keys_str_mv AT rociosoldati wcn24828phase3commodoretrialsofcrovalimabinparoxysmalnocturnalhemoglobinuriapnhimpactonkidneyfunction
AT sashasreckovic wcn24828phase3commodoretrialsofcrovalimabinparoxysmalnocturnalhemoglobinuriapnhimpactonkidneyfunction
AT cristianbrocchieri wcn24828phase3commodoretrialsofcrovalimabinparoxysmalnocturnalhemoglobinuriapnhimpactonkidneyfunction
AT pattyleon wcn24828phase3commodoretrialsofcrovalimabinparoxysmalnocturnalhemoglobinuriapnhimpactonkidneyfunction
AT nadieshbalachandran wcn24828phase3commodoretrialsofcrovalimabinparoxysmalnocturnalhemoglobinuriapnhimpactonkidneyfunction
AT marianneuguen wcn24828phase3commodoretrialsofcrovalimabinparoxysmalnocturnalhemoglobinuriapnhimpactonkidneyfunction
AT simonbuatois wcn24828phase3commodoretrialsofcrovalimabinparoxysmalnocturnalhemoglobinuriapnhimpactonkidneyfunction